Ajanta Pharma (India) Today
| AJANTPHARM | 2,960 14.55 0.49% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Ajanta Pharma is trading at 2960.05 as of the 24th of November 2024. This is a 0.49 percent increase since the beginning of the trading day. The stock's open price was 2945.5. Ajanta Pharma has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ajanta Pharma Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Ajanta Pharma is entity of India. It is traded as Stock on NSE exchange. The company has 124.91 M outstanding shares. More on Ajanta Pharma Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Ajanta Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ajanta Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ajanta Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Operations | Satish Pharm | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Ajanta Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ajanta Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAjanta Pharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ajanta Pharma's financial leverage. It provides some insight into what part of Ajanta Pharma's total assets is financed by creditors.
| |||||
Ajanta Pharma Limited (AJANTPHARM) is traded on National Stock Exchange of India in India and employs 8,073 people. Ajanta Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 369.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ajanta Pharma's market, we take the total number of its shares issued and multiply it by Ajanta Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ajanta Pharma Limited operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 124.91 M outstanding shares.
Ajanta Pharma generates positive cash flow from operations, but has no cash available
Check Ajanta Pharma Probability Of Bankruptcy
Ownership AllocationAjanta Pharma holds a total of 124.91 Million outstanding shares. Ajanta Pharma Limited shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.47 percent of Ajanta Pharma Limited outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ajanta Ownership Details
Ajanta Pharma Limited Risk Profiles
Although Ajanta Pharma's alpha and beta are two of the key measurements used to evaluate Ajanta Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.75 | |||
| Standard Deviation | 2.25 | |||
| Variance | 5.08 | |||
| Risk Adjusted Performance | (0.0003) |
Ajanta Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ajanta Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Ajanta Pharma Corporate Management
Elected by the shareholders, the Ajanta Pharma's board of directors comprises two types of representatives: Ajanta Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ajanta. The board's role is to monitor Ajanta Pharma's management team and ensure that shareholders' interests are well served. Ajanta Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ajanta Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pankaj Barbind | Deputy Sustainability | Profile | |
| Arvind Agrawal | Chief Officer | Profile | |
| Thampy Jacob | Senior HR | Profile | |
| Madhusudan Agrawal | Executive Board | Profile | |
| Madhusudan BSc | Executive Board | Profile |
Other Information on Investing in Ajanta Stock
Ajanta Pharma financial ratios help investors to determine whether Ajanta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajanta with respect to the benefits of owning Ajanta Pharma security.